Standardization and cross validation of alloreactive IFNÎ³ ELISPOT assays within the clinical trials in organ transplantation consortium.

Ashoor, I; Najafian, N; Korin, Y; Reed, E F; Mohanakumar, T; Ikle, D; Heeger, P S; Lin, M

Ashoor, I; Najafian, N; Korin, Y; Reed, E F; Mohanakumar, T; Ikle, D; Heeger, P S; Lin, M.

Affiliation

Ashoor I; Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Children's Hospital, Boston, MA, USA.

Am J Transplant ; 13(7): 1871-9, 2013 Jul.

Article in En | MEDLINE | ID: mdl-23710568

Subject(s)

Clinical Trials as Topic; Graft Survival/immunology; Monitoring, Immunologic/standards; Organ Transplantation/standards; T-Lymphocytes/immunology; Tissue Donors; Enzyme-Linked Immunosorbent Assay; Enzyme-Linked Immunospot Assay; Humans; Monitoring, Immunologic/methods; Pilot Projects; Reproducibility of Results; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / T-Lymphocytes / Monitoring, Immunologic / Clinical Trials as Topic / Organ Transplantation / Graft Survival Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2013 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google